- Home
- FUSB vs BYSI Comparison
FUSB vs BYSI Comparison
Compare FUSB & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- BYSI
- Stock Information
- Founded
- FUSB 1952
- BYSI 2010
- Country
- FUSB United States
- BYSI United States
- Employees
- FUSB N/A
- BYSI N/A
- Industry
- FUSB Major Banks
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- FUSB Finance
- BYSI Health Care
- Exchange
- FUSB Nasdaq
- BYSI Nasdaq
- Market Cap
- FUSB 69.3M
- BYSI 80.6M
- IPO Year
- FUSB N/A
- BYSI 2017
- Fundamental
- Price
- FUSB $12.00
- BYSI $1.82
- Analyst Decision
- FUSB
- BYSI
- Analyst Count
- FUSB 0
- BYSI 0
- Target Price
- FUSB N/A
- BYSI N/A
- AVG Volume (30 Days)
- FUSB 3.9K
- BYSI 26.7K
- Earning Date
- FUSB 10-23-2025
- BYSI 11-11-2025
- Dividend Yield
- FUSB 2.33%
- BYSI N/A
- EPS Growth
- FUSB N/A
- BYSI N/A
- EPS
- FUSB 0.97
- BYSI N/A
- Revenue
- FUSB $36,046,000.00
- BYSI N/A
- Revenue This Year
- FUSB N/A
- BYSI N/A
- Revenue Next Year
- FUSB N/A
- BYSI N/A
- P/E Ratio
- FUSB $12.08
- BYSI N/A
- Revenue Growth
- FUSB N/A
- BYSI N/A
- 52 Week Low
- FUSB $10.30
- BYSI $0.98
- 52 Week High
- FUSB $14.30
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- FUSB 50.32
- BYSI 43.82
- Support Level
- FUSB $11.00
- BYSI $1.67
- Resistance Level
- FUSB $12.22
- BYSI $1.84
- Average True Range (ATR)
- FUSB 0.57
- BYSI 0.11
- MACD
- FUSB 0.07
- BYSI 0.02
- Stochastic Oscillator
- FUSB 61.98
- BYSI 45.45
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.